k.brandl_de
TL3 Translator · DE · Leipzig, DE
German translation and the German regulatory picture, which is not the EU picture.
Joined 8 November 2024 · last posted 3d · groups: wiki-editors, translators, regional-eu
136 posts, newest first. Showing up to 150.
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #13 · Compounds › Retatrutide · 25 Jul 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Documenting an adverse event properly Replied, post #20 · Safety › Adverse events · 24 Jul 2026 · 1 like Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #62 · Access › Insurance & coverage · 24 Jul 2026 · 10 likes I read post #60 twice before replying, because I had assumed the opposite. Documentation your clinician can provide: letters from clinicians describing why standard…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #106 · Analytics › Home & field testing · 20 Jul 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Why the Start Here categories exist, and what they are not for Replied, post #16 · Start Here › Welcome · 20 Jul 2026 · 1 like The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #101 · Sourcing › Independent verification · 18 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Substitution between formats during a shortage — what changed since Replied, post #14 · Access › Shortages · 15 Jul 2026 · 10 likes Worth separating two things that post #10 runs together. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #6 · Compounds › Other compounds · 15 Jul 2026 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #127 · Start Here › How to Ask · 14 Jul 2026 · 2 likes Worth separating two things that post #123 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Common supplements people ask about, assessed one at a time Replied, post #22 · Practice › Interactions · 8 Jul 2026 · 1 like Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
What a reversed-phase purity number actually is Replied, post #34 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 1 like Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Journal club: what we got wrong in an earlier session Replied, post #51 · Evidence › Journal club · 4 Jul 2026 · 17 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #47 · Practice › Administration · 25 Jun 2026 · 10 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
The anatomy of a question that gets answered within an hour Replied, post #89 · Start Here › How to Ask · 24 Jun 2026 · 12 likes On post #85 — agreed on the reasoning, with one qualification. The specific question in the title is more useful than you might think. A title like "a question I have"…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #4 · Compounds › Secretagogues & GH axis · 21 Jun 2026 · 4 likes post #3 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
-
Journal club: what we got wrong in an earlier session Replied, post #15 · Evidence › Journal club · 19 Jun 2026 · 26 likes Worth separating two things that post #11 runs together. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #26 · Documentation › Doc review · 19 Jun 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #62 · Outcomes › Progress reports · 19 Jun 2026 · 0 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
A parcel stationary at a customs facility for nine days Replied, post #70 · Sourcing › Logistics · 13 Jun 2026 · 2 likes Worth separating two things that post #66 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #27 · Compounds › Oral incretins · 4 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #2 · Clinical › Bloodwork · 1 Jun 2026 · 1 like On the opening post — agreed on the reasoning, with one qualification. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ…
-
Does a peptide degrade silently, with no visual change? Replied, post #32 · Practice › Storage & stability · 22 May 2026 · 9 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
About the HPLC & UHPLC category Replied, post #3 · Analytics › HPLC & UHPLC · 17 May 2026 · 12 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Personal import allowances, compared — a second dataset Replied, post #124 · Access › International · 16 May 2026 · 22 likes I read post #122 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #9 · Outcomes › Progress reports · 12 May 2026 · 20 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Run-in periods and the population they select Replied, post #110 · Evidence › Trials · 2 May 2026 · 17 likes This follows post #107 rather than contradicting it. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #22 · Clinical › Comorbidities · 30 Apr 2026 · 19 likes This follows post #19 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Revisiting: What pooling buys you and what it destroys Replied, post #9 · Evidence › Meta-analyses · 29 Apr 2026 · 30 likes This follows post #6 rather than contradicting it. Publication bias: what did not get published? Small studies with negative results are less likely to be published…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #16 · Wellbeing › Sleep · 28 Apr 2026 · 21 likes Worth separating two things that post #12 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #90 · Research Methods › Statistics · 28 Apr 2026 · 1 like Coming back to post #88, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #23 · Practice › Reconstitution · 24 Apr 2026 · 17 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
The best-written scientific paper you have read Replied, post #16 · Lounge › Off topic · 24 Apr 2026 · 16 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #92 · Practice › Reconstitution · 23 Apr 2026 · 0 likes On post #88 — agreed on the reasoning, with one qualification. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #77 · Practice › Reconstitution · 23 Apr 2026 · 17 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Revisiting: Absolute versus relative contraindications Replied, post #70 · Safety › Contraindications · 19 Apr 2026 · 2 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #100 · Practice › Reconstitution · 15 Apr 2026 · 21 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Spike-and-recover accuracy for a peptide assay Replied, post #98 · Analytics › Method validation · 10 Apr 2026 · 7 likes post #97 is right about the mechanism and I think understates the practical bit. Stability-indicating method: one that can separate a compound from its degradation…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #102 · Analytics › Mass spectrometry · 10 Apr 2026 · 14 likes Picking up post #99: that is the part I would want checked first. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #19 · Practice › Dosing & titration · 31 Mar 2026 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #119 · Pharmacology › Pharmacokinetics · 30 Mar 2026 · 0 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #35 · Sourcing › Independent verification · 29 Mar 2026 · 4 likes This follows post #32 rather than contradicting it. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #86 · Lounge › Introductions · 16 Mar 2026 · 11 likes Worth separating two things that post #82 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #16 · Clinical › Bloodwork · 16 Mar 2026 · 14 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #67 · Sourcing › Regulatory · 12 Mar 2026 · 31 likes I read post #65 twice before replying, because I had assumed the opposite. Off-label use and medical practice: clinicians can prescribe approved medications off-label…
-
A site rotation scheme that is easy enough to actually follow Replied, post #18 · Practice › Administration · 11 Mar 2026 · 31 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Why the timeline is on the right and not the left — what changed since Replied, post #4 · marked as the solution · Meta › Site feedback · 7 Mar 2026 · 10 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #7 · Practice › Interactions · 7 Mar 2026 · 20 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Five questions in one post gets you one answer — how to split them Replied, post #23 · Start Here › How to Ask · 3 Mar 2026 · 11 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Preprint servers and what screening they do Replied, post #71 · Evidence › Preprints · 28 Feb 2026 · 18 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Cardiovascular risk: reading the outcome trials as a set Replied, post #5 · Clinical › Comorbidities · 25 Feb 2026 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #21 · Analytics › Impurities & related substances · 22 Feb 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #54 · Clinical › Bloodwork · 22 Feb 2026 · 12 likes On post #50 — agreed on the reasoning, with one qualification. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 15 Feb 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #77 · Documentation › Wiki requests · 8 Feb 2026 · 3 likes post #76 answers the question as asked. The question underneath it is different. Cross-referencing: if you notice two pages that should reference each other but do not,…
-
Trifluoroacetate content and its consequences Replied, post #19 · Analytics › Impurities & related substances · 25 Jan 2026 · 24 likes Picking up post #16: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coming back to: Training through a dose escalation week Replied, post #2 · Nutrition & Training › Resistance training · 1 Jan 2026 · 17 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Aggregates and why a purity assay may miss them entirely Replied, post #39 · Analytics › Impurities & related substances · 30 Dec 2025 · 27 likes Picking up post #36: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #81 · Compounds › Semaglutide · 30 Dec 2025 · 32 likes On post #77 — agreed on the reasoning, with one qualification. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #77 · Practice › Side effects · 29 Dec 2025 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Search filters: what is missing Replied, post #13 · Meta › Site feedback · 28 Dec 2025 · 19 likes post #12 answers the question as asked. The question underneath it is different. Feature requests: if the site would work better with a feature it does not have (better…
-
Batch date after test date, and other internal inconsistencies Replied, post #28 · Analytics › COA interpretation · 18 Dec 2025 · 0 likes post #27 answers the question as asked. The question underneath it is different. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #81 · Analytics › Home & field testing · 17 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #11 · Pharmacology › Receptor biology · 13 Dec 2025 · 8 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #111 · Documentation › Doc review · 13 Dec 2025 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Publishing an inconvenient result: a case study — the long version Replied, post #61 · Sourcing › Independent verification · 6 Dec 2025 · 18 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #4 · Sourcing › Logistics · 4 Dec 2025 · 21 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #5 · Compounds › Tirzepatide · 29 Nov 2025 · 10 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #25 · Compounds › Other compounds · 23 Nov 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #109 · Start Here › How to Ask · 17 Nov 2025 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #9 · Analytics › Impurities & related substances · 14 Nov 2025 · 22 likes post #8 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] What steady state means for the decision to escalate Replied, post #33 · Practice › Dosing & titration · 8 Nov 2025 · 19 likes This follows post #30 rather than contradicting it. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #76 · Documentation › Doc review · 17 Oct 2025 · 0 likes This follows post #73 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Sleep tracking data and its considerable limitations Replied, post #2 · Wellbeing › Sleep · 14 Oct 2025 · 4 likes This follows the opening post rather than contradicting it. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #144 · Practice › Reconstitution · 13 Oct 2025 · 1 like On post #140 — agreed on the reasoning, with one qualification. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #46 · Compounds › Oral incretins · 6 Oct 2025 · 9 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #38 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 1 like The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Why the timeline is on the right and not the left Replied, post #67 · Meta › Site feedback · 12 Sep 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #4 · Evidence › Study critique · 12 Sep 2025 · 0 likes This follows post #3 rather than contradicting it. Bias towards the null and bias away from the null: different criticisms have different directions. Differential…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #25 · Practice › Storage & stability · 5 Sep 2025 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #93 · Compounds › Cagrilintide & amylin analogues · 4 Sep 2025 · 3 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #95 · Data & Tools › Calculators · 26 Aug 2025 · 0 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Revisiting: German, French and Dutch differences, compared Replied, post #61 · Regional › European Union · 20 Aug 2025 · 14 likes Picking up post #58: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #59 · Evidence › Journal club · 18 Aug 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Are there stupid questions here? A staff answer, at length Replied, post #70 · Start Here › Welcome · 14 Aug 2025 · 3 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #100 · Compounds › Repair & healing peptides · 12 Aug 2025 · 26 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
A request that was declined, and the reasoning — a second dataset Replied, post #24 · Documentation › Wiki requests · 7 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Sequence verification for an obscure compound: how it is done Replied, post #113 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Sequence verification for an obscure compound: how it is done Replied, post #104 · Compounds › Other compounds · 25 Jul 2025 · 6 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Coming back to: Official shortage notices and what they authorise Replied, post #66 · Access › Shortages · 23 Jul 2025 · 1 like post #65 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #42 · Clinical › Special populations · 17 Jul 2025 · 17 likes On post #38 — agreed on the reasoning, with one qualification. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it…
-
Which panel is worth repeating and which is worth ignoring Replied, post #57 · Clinical › Bloodwork · 10 Jul 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sodium, potassium and magnesium when intake drops Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 7 Jul 2025 · 2 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Publishing an inconvenient result: a case study Replied, post #44 · Sourcing › Independent verification · 4 Jul 2025 · 0 likes On post #40 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Counter-ion content and its effect on measured mass Replied, post #81 · Analytics › Mass spectrometry · 3 Jul 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #62 · Pharmacology › Pharmacokinetics · 24 Jun 2025 · 4 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #13 · Compounds › Oral incretins · 20 Jun 2025 · 31 likes This follows post #10 rather than contradicting it. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #34 · Practice › Dosing & titration · 14 Jun 2025 · 0 likes post #33 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
A report I filed that turned out to be wrong, and the correction Replied, post #88 · Sourcing › Vendor reports · 6 Jun 2025 · 22 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Coming back to: Getting a referral rather than a refusal Replied, post #30 · Clinical › Prescriber conversations · 4 Jun 2025 · 14 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #78 · Practice › Reconstitution · 26 May 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 25 Apr 2025 · 4 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Coverage for the indication versus for the drug Replied, post #42 · Access › Insurance & coverage · 25 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #12 · Sourcing › Independent verification · 25 Apr 2025 · 0 likes Worth separating two things that post #8 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Risk-of-bias tools and the judgement they conceal Started this topic · Evidence › Meta-analyses · 16 Apr 2025 · 0 likes Risk-of-bias tools and the judgement they conceal Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med ,…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #16 · Sourcing › Independent verification · 8 Apr 2025 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. Blind sampling: submitting without the laboratory or seller knowing the source…
-
Carryover and the ghost peak from last week's standard Replied, post #12 · Analytics › HPLC & UHPLC · 2 Apr 2025 · 11 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Retatrutide dose escalation in the published trials Replied, post #66 · Compounds › Retatrutide · 30 Mar 2025 · 3 likes I read post #64 twice before replying, because I had assumed the opposite. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not…
-
Coverage for the indication versus for the drug Replied, post #9 · Access › Insurance & coverage · 24 Mar 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #114 · Compounds › Semaglutide · 23 Mar 2025 · 17 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #5 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 6 likes On the opening post — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down…
-
An orphaned page with no inbound links Replied, post #16 · Meta › Wiki maintenance · 10 Mar 2025 · 1 like Coming back to post #14, because the follow-up matters more than the original answer. Scope creep: if a page is attempting too much, suggesting it split into multiple…
-
Consistent declarations and why they matter more than clever ones Replied, post #140 · Sourcing › Logistics · 7 Mar 2025 · 1 like This follows post #137 rather than contradicting it. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #16 · Evidence › Meta-analyses · 28 Jan 2025 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #24 · Analytics › Mass spectrometry · 11 Jan 2025 · 2 likes This follows post #21 rather than contradicting it. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge…
-
Follow-up: Individual participant data versus aggregate data Replied, post #72 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Follow-up: Individual participant data versus aggregate data Replied, post #25 · Evidence › Meta-analyses · 8 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] New subcategory: rationale and scope Replied, post #119 · Meta › Announcements · 4 Jan 2025 · 0 likes On post #115 — agreed on the reasoning, with one qualification. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members…
-
When "no data" is the complete and final answer Replied, post #55 · Compounds › Other compounds · 1 Jan 2025 · 9 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #101 · Compounds › Oral incretins · 28 Dec 2024 · 4 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Scheduled maintenance and what will be unavailable Started this topic · Meta › Announcements · 22 Dec 2024 · 16 likes Scheduled maintenance and what will be unavailable Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #9 · Compounds › Semaglutide · 16 Dec 2024 · 1 like post #8 answers the question as asked. The question underneath it is different. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #89 · Analytics › Method validation · 7 Dec 2024 · 0 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #53 · Compounds › Semaglutide · 1 Dec 2024 · 25 likes On post #49 — agreed on the reasoning, with one qualification. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #142 · Compounds › Repair & healing peptides · 25 Nov 2024 · 0 likes Picking up post #139: that is the part I would want checked first. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #77 · Clinical › Prescriber conversations · 19 Nov 2024 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
EMA product information as a primary source — does this still hold? Replied, post #134 · Regional › European Union · 18 Nov 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Moderation log format change Started this topic · Meta › Announcements · 17 Oct 2024 · 45 likes Revisiting: Moderation log format change Writing it up because I had to work it out twice and would rather nobody else did. Process question about how this site works.…
-
When to suspect the method rather than the sample Replied, post #17 · Analytics › Method validation · 28 Sep 2024 · 4 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #88 · Sourcing › Independent verification · 26 Sep 2024 · 29 likes I read post #86 twice before replying, because I had assumed the opposite. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
Irish differences from the UK position Replied, post #8 · Regional › UK & Ireland · 25 Sep 2024 · 10 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #3 · Compounds › Other compounds · 14 Sep 2024 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #8 · Compounds › Semaglutide · 8 Sep 2024 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The topic list is dense — is that deliberate? Replied, post #11 · Meta › Site feedback · 5 Aug 2024 · 3 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Guidelines revision: what changed and why Replied, post #12 · Meta › Announcements · 25 Jul 2024 · 24 likes On post #8 — agreed on the reasoning, with one qualification. Notifications: watching this subcategory means you receive notifications when announcements are posted.…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #122 · Compounds › Retatrutide · 24 Jul 2024 · 29 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Promotion criteria, and the one that stops most nominations Replied, post #17 · Documentation › Doc review · 13 Jul 2024 · 3 likes post #16 answers the question as asked. The question underneath it is different. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the…